300+ investors in your industry, stage, and region Get
Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Pakistan
Sudan
Tajikistan
Zambia
Poland
Romania
Oman
Puerto Rico
Guernsey
Cameroon
Colombia
China
Costa Rica
Armenia
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Paraguay
France
South Africa
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
Germany
India
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Asia
Albania
Dominican Republic
Angola
Europe
Argentina
Cyprus
Spain
Qatar
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Mongolia
Bangladesh
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database

Diamond Biofund Inc.

VC Fund

Taipei, Taiwan

Diamond Biofund Inc. is a VC fund in Taipei focused on Health Care and Biotechnology. Diamond BioFund is a company that provides funds in life science sector, dedicated to biotechnology innovation.

Total investments:
9
Last investment:
Lead investor:
22%

Last updated:

Industries Diamond Biofund Inc. invests in

Health CareBiotechnologyMedicalPharmaceuticalGenetics

Stages Diamond Biofund Inc. invests in

SeedVenture - Series UnknownSeries ASeries BSeries C

Countries Diamond Biofund Inc. invests in

United StatesTaiwanChinaIsrael

Investment Focus

Industry

  • Health Care 8 (89%)
  • Biotechnology 6 (67%)
  • Medical 3 (33%)
  • Pharmaceutical 2 (22%)
  • Genetics 1 (11%)
See all 14 industries →

Stage

  • Seed 3 (33%)
  • Venture - Series Unknown 2 (22%)
  • Series A 1 (11%)
  • Series B 1 (11%)
  • Series C 1 (11%)
See all 6 stages →

Country

  • United States 4 (44%)
  • Taiwan 3 (33%)
  • China 1 (11%)
  • Israel 1 (11%)

Investments

CompanyDescriptionRoundLinks
Rejuvenate Bio is a biotechnology company that develops novel gene therapies for dogs. The company's therapy provides a solution for the mitral valve disease to stop the progression of heart failure in dogs, thus providing pets with extended overall health and maximal lifespan. It was founded in 2017 and is based in San Diego, CA. Venture - Series Unknown / Jul 01, 2024
StemCyte, Inc. operates as an umbilical cord blood stem cell transplantation and therapeutic products company. It provides cord blood products to transplant centers for life-threatening diseases. The company's products are used to treat patients suffering from various blood cancers, and immune and genetic disorders. StemCyte, Inc. was foundedin 1997 and is headquartered in Covina, California. It operates umbilical cord blood storage facilities in California and Taiwan. The company has locations in the United States, India, and Taiwan. $6.4M / Venture - Series Unknown / Nov 08, 2023
ImmunAdd is a biotech startup developing fully synthetic saponin-based vaccine adjuvants. Seed / Jan 01, 2023
Bilayer Therapeutics is a biotech company that develops a first-in-class therapeutic for constipation and other diseases of the colon. The company was founded in 2020 and is headquartered in Cambridge, Massachusetts. Seed / Jan 01, 2022
EyeYon Medical is an Israeli start-up company that develops innovative medical devices for the treatment of corneal edema.EyeYon Medical was founded by Dr. Daphna Ofer, a senior ophthalmologist, Dr. Arie Marcovich, a senior cornea surgeon, and Nahum Ferera, an experienced business executive. The company operates within the Van Leer TechnologyIncubator. $25M / Series C / Mar 15, 2021
Dr. Young holds a PhD degree in agronomy and soil science awarded by University of Hawaii. He is the pioneer in the field of organic fertilizer and soil microorganisms in Taiwan and was awarded the Academician honor in 2016.TTT® technology is the world’s only destructive and innovative concept that revolutionizes the traditional microbialcomposting process with the use of enzymes to stabilize and mature organic wastes. It raises the maturing efficiency more than 100-fold, and our zero pollution composting technology is able to avoid bad smell and waste water produced during the process.Dr. Young has profound influence on the industry in Taiwan and will lead our business to expand internationally as well as establish our group at the top of circular economy.•Broad microorganism and enzyme database:We possess more than 7,000 bacterial isolates that can provide functional and optimized enzyme formulations for different composting materials. •Professional know-how service:The rapid composting technology is a combination of microbiology, biochemistry, soil science, physics, as well as long term practical experiences. It can provide all-around total solution services for any organic wastes. •No more NIMBY protests:Rapid composting technology is pollution-free and can resolve the protests from the neighborhood. Corporate Round / Oct 18, 2018
Yuezige provides a range of medical care and LOHAS experiences during pregnancy and childbirth. They also offer organic maternity care and SPA services. They serve mother, father, infant, body, mind, and spirit from the early stages of pregnancy. $1.6M / Series A / Sep 22, 2015
Ativa Medical is a medical device manufacturing company that is working to make diagnostic test results available in moments, rather than hours and days. The company specializes in the fields of medical device development, point of care diagnostics, microfluidics, and hematology.The company was founded in 2008 and headquartered in Saint Paul,Minnesota. $15M / Series B / Sep 17, 2015
Sinew Pharma is a biopharmaceutical company with a focus on integrated new drugs, R&D, and building a platform for regulating hepatic enzymes and genes. Seed / Dec 09, 2014

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Pakistan
Sudan
Tajikistan
Zambia
Poland
Romania
Oman
Puerto Rico
Guernsey
Cameroon
Colombia
China
Costa Rica
Armenia
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Paraguay
France
South Africa
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
Germany
India
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Asia
Albania
Dominican Republic
Angola
Europe
Argentina
Cyprus
Spain
Qatar
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Mongolia
Bangladesh
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Diamond Biofund Inc. invest in?

Diamond Biofund Inc. invests primarily in Health Care, Biotechnology and Medical startups, most often at Seed and Venture - Series Unknown stage. Most of the 9 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did Diamond Biofund Inc. last invest?

The most recent investment recorded for Diamond Biofund Inc. closed in Jul 2024. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Diamond Biofund Inc. Find emails